Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis

Atherosclerosis

Volumn 233, Issue 1, 2014, Pages 104-112

  Alexopoulos, Nikolaos ^a   Katritsis, Demosthenes ^a   Raggi, Paolo ^b,c  

^a Cardiology Department   (Greece)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MAZANKOWSKI ALBERTA HEART INSTITUTE   (Canada)

Author keywords

Atherosclerosis; Coronary artery disease; Visceral adipose tissue

Indexed keywords

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; VISCERAL ADIPOSE TISSUE;

ATHEROSCLEROSIS; CYTOKINES; FATTY ACIDS, NONESTERIFIED; HUMANS; INFLAMMATION; INTRA-ABDOMINAL FAT; PERICARDIUM;

EID: 84893827916     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.12.023     Document Type: Review

References (102)

1. Shen W., Wang Z., Punyanita M., et al. Adipose tissue quantification by imaging methods: a proposed classification. Obes Res 2003, 11(1):5-16.
2. Wu J., Cohen P., Spiegelman B.M. Adaptive thermogenesis in adipocytes: is beige the new brown?. Genes Dev 2013, 27(3):234-250.
3. Barak Y., Nelson M.C., Ong E.S., et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999, 4(4):585-595.
4. Despres J.P. Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012, 126(10):1301-1313.
5. Raggi P., Alakija P. Epicardial adipose tissue: a long-overlooked marker of risk of cardiovascular disease. Atherosclerosis 2013, 229(1):32-33.
6. Nakamura T., Tokunaga K., Shimomura I., et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994, 107(2):239-246.
7. Mahabadi A.A., Massaro J.M., Rosito G.A., et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 2009, 30(7):850-856.
8. Marques M.D., Santos R.D., Parga J.R., et al. Relation between visceral fat and coronary artery disease evaluated by multidetector computed tomography. Atherosclerosis 2010, 209(2):481-486.
9. Lear S.A., Humphries K.H., Kohli S., Frohlich J.J., Birmingham C.L., Mancini G.B. Visceral adipose tissue, a potential risk factor for carotid atherosclerosis: results of the Multicultural Community Health Assessment Trial (M-CHAT). Stroke 2007, 38(9):2422-2429.
10. Lee Y.H., Lee S.H., Jung E.S., et al. Visceral adiposity and the severity of coronary artery disease in middle-aged subjects with normal waist circumference and its relation with lipocalin-2 and MCP-1. Atherosclerosis 2010, 213(2):592-597.
11. Ohashi N., Yamamoto H., Horiguchi J., et al. Visceral fat accumulation as a predictor of coronary artery calcium as assessed by multislice computed tomography in Japanese patients. Atherosclerosis 2009, 202(1):192-199.
12. Choi S.Y., Kim D., Oh B.H., et al. General and abdominal obesity and abdominal visceral fat accumulation associated with coronary artery calcification in Korean men. Atherosclerosis 2010, 213(1):273-278.
13. Liu J., Musani S.K., Bidulescu A., et al. Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study. Atherosclerosis 2012, 224(2):521-525.
14. Ditomasso D., Carnethon M.R., Wright C.M., Allison M.A. The associations between visceral fat and calcified atherosclerosis are stronger in women than men. Atherosclerosis 2010, 208(2):531-536.
15. Imai A., Komatsu S., Ohara T., et al. Visceral abdominal fat accumulation predicts the progression of noncalcified coronary plaque. Atherosclerosis 2012, 222(2):524-529.
16. Ohashi N., Yamamoto H., Horiguchi J., et al. Association between visceral adipose tissue area and coronary plaque morphology assessed by CT angiography. JACC Cardiovasc Imaging 2010, 3(9):908-917.
17. Nicklas B.J., Penninx B.W., Cesari M., et al. Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study. Am J Epidemiol 2004, 160(8):741-749.
18. Britton K.A., Massaro J.M., Murabito J.M., Kreger B.E., Hoffmann U., Fox C.S. Body fat distribution, incident cardiovascular disease, Cancer, and all-cause mortality. JAm Coll Cardiol 2013, 62:921-925.
19. Iacobellis G., Willens H.J. Echocardiographic epicardial fat: a review of research and clinical applications. JAm Soc Echocardiogr 2009, 22(12):1311-1319. quiz 1417-1318.
20. Taguchi R., Takasu J., Itani Y., et al. Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis 2001, 157(1):203-209.
21. Ding J., Hsu F.C., Harris T.B., et al. The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2009, 90(3):499-504.
22. Greif M., Becker A., von Ziegler F., et al. Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2009, 29(5):781-786.
23. Yong H.S., Kim E.J., Seo H.S., et al. Pericardial fat is more abundant in patients with coronary atherosclerosis and even in the non-obese patients: evaluation with cardiac CT angiography. Int J Cardiovasc Imaging 2010, 26(Suppl.1):53-62.
24. Sarin S., Wenger C., Marwaha A., et al. Clinical significance of epicardial fat measured using cardiac multislice computed tomography. Am J Cardiol 2008, 102(6):767-771.
25. Silaghi A., Piercecchi-Marti M.D., Grino M., et al. Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obesity (Silver Spring) 2008, 16(11):2424-2430.
26. Schlett C.L., Ferencik M., Kriegel M.F., et al. Association of pericardial fat and coronary high-risk lesions as determined by cardiac CT. Atherosclerosis 2012, 222(1):129-134.
27. Bachar G.N., Dicker D., Kornowski R., Atar E. Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects. Am J Cardiol 2012, 110(4):534-538.
28. Iacobellis G., Lonn E., Lamy A., Singh N., Sharma A.M. Epicardial fat thickness and coronary artery disease correlate independently of obesity. Int J Cardiol 2011, 146(3):452-454.
29. Bastarrika G., Broncano J., Schoepf U.J., et al. Relationship between coronary artery disease and epicardial adipose tissue quantification at cardiac CT: comparison between automatic volumetric measurement and manual bidimensional estimation. Acad Radiol 2010, 17(6):727-734.
30. Konishi M., Sugiyama S., Sugamura K., et al. Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease. Atherosclerosis 2010, 209(2):573-578.
31. Wang T.D., Lee W.J., Shih F.Y., et al. Association of epicardial adipose tissue with coronary atherosclerosis is region-specific and independent of conventional risk factors and intra-abdominal adiposity. Atherosclerosis 2010, 213(1):279-287.
32. Rajani R., Shmilovich H., Nakazato R., et al. Relationship of epicardial fat volume to coronary plaque, severe coronary stenosis, and high-risk coronary plaque features assessed by coronary CT angiography. JCardiovasc Comput Tomogr 2013, 7(2):125-132.
33. Alexopoulos N., McLean D.S., Janik M., Arepalli C.D., Stillman A.E., Raggi P. Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 2010, 210(1):150-154.
34. Ito T., Suzuki Y., Ehara M., et al. Impact of epicardial fat volume on coronary artery disease in symptomatic patients with a zero calcium score. Int J Cardiol 2012, 167:2582-2588.
35. Gorter P.M., de Vos A.M., van der Graaf Y., et al. Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol 2008, 102(4):380-385.
36. Chaowalit N., Somers V.K., Pellikka P.A., Rihal C.S., Lopez-Jimenez F. Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis 2006, 186(2):354-359.
37. Dagvasumberel M., Shimabukuro M., Nishiuchi T., et al. Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: a 3-dimensional cardiac computed tomography imaging study in Japanese subjects. Cardiovasc Diabetol 2012, 11:106.
38. Wu F.Z., Huang Y.L., Wang Y.C., et al. Impact of location of epicardial adipose tissue, measured by coronary artery calcium-scoring computed tomography on obstructive coronary artery disease. Am J Cardiol 2013, 112:943-949.
39. Ding J., Kritchevsky S.B., Harris T.B., Burke G.L., Detrano R.C., Szklo M., Jeffrey Carr J. Multi-ethnic study of A. The association of pericardial fat with calcified coronary plaque. Obesity (Silver Spring) 2008, 16(8):1914-1919.
40. Liu J., Fox C.S., Hickson D., et al. Pericardial adipose tissue, atherosclerosis, and cardiovascular disease risk factors: the Jackson heart study. Diabetes Care 2010, 33(7):1635-1639.
41. Divers J., Wagenknecht L.E., Bowden D.W., et al. Regional adipose tissue associations with calcified atherosclerotic plaque: African American-diabetes heart study. Obesity (Silver Spring) 2010, 18(10):2004-2009.
42. Huang G., Wang D., Zeb I., et al. Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis 2012, 221(1):198-205.
43. Yun C.H., Lin T.Y., Wu Y.J., et al. Pericardial and thoracic peri-aortic adipose tissues contribute to systemic inflammation and calcified coronary atherosclerosis independent of body fat composition, anthropometric measures and traditional cardiovascular risks. Eur J Radiol 2012, 81(4):749-756.
44. Yun C.H., Bezerra H.G., Wu T.H., et al. The normal limits, subclinical significance, related metabolic derangements and distinct biological effects of body site-specific adiposity in relatively healthy population. PLoS One 2013, 8(4):e61997.
45. Nakanishi R., Rajani R., Cheng V.Y., et al. Increase in epicardial fat volume is associated with greater coronary artery calcification progression in subjects at intermediate risk by coronary calcium score: a serial study using non-contrast cardiac CT. Atherosclerosis 2011, 218(2):363-368.
46. Oka T., Yamamoto H., Ohashi N., et al. Association between epicardial adipose tissue volume and characteristics of non-calcified plaques assessed by coronary computed tomographic angiography. Int J Cardiol 2012, 161(1):45-49.
47. Park J.S., Choi S.Y., Zheng M., et al. Epicardial adipose tissue thickness is a predictor for plaque vulnerability in patients with significant coronary artery disease. Atherosclerosis 2013, 226(1):134-139.
48. Ito T., Nasu K., Terashima M., et al. The impact of epicardial fat volume on coronary plaque vulnerability: insight from optical coherence tomography analysis. Eur Heart J Cardiovasc Imaging 2012, 13(5):408-415.
49. Harada K., Amano T., Uetani T., et al. Cardiac 64-multislice computed tomography reveals increased epicardial fat volume in patients with acute coronary syndrome. Am J Cardiol 2011, 108(8):1119-1123.
50. Janik M., Hartlage G., Alexopoulos N., et al. Epicardial adipose tissue volume and coronary artery calcium to predict myocardial ischemia on positron emission tomography-computed tomography studies. JNucl Cardiol 2010, 17(5):841-847.
51. Nakazato R., Dey D., Cheng V.Y., et al. Epicardial fat volume and concurrent presence of both myocardial ischemia and obstructive coronary artery disease. Atherosclerosis 2012, 221(2):422-426.
52. Tamarappoo B., Dey D., Shmilovich H., et al. Increased pericardial fat volume measured from noncontrast CT predicts myocardial ischemia by SPECT. JACC Cardiovasc Imaging 2010, 3(11):1104-1112.
53. Sade L.E., Eroglu S., Bozbas H., et al. Relation between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries. Atherosclerosis 2009, 204(2):580-585.
54. Bucci M., Joutsiniemi E., Saraste A., et al. Intrapericardial, but not extrapericardial, fat is an independent predictor of impaired hyperemic coronary perfusion in coronary artery disease. Arterioscler Thromb Vasc Biol 2011, 31(1):211-218.
55. Otaki Y., Rajani R., Cheng V.Y., et al. The relationship between epicardial fat volume and incident coronary artery calcium. JCardiovasc Comput Tomogr 2011, 5(5):310-316.
56. Yerramasu A., Dey D., Venuraju S., et al. Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis. Atherosclerosis 2012, 220(1):223-230.
57. Shmilovich H., Dey D., Cheng V.Y., et al. Threshold for the upper normal limit of indexed epicardial fat volume: derivation in a healthy population and validation in an outcome-based study. Am J Cardiol 2011, 108(11):1680-1685.
58. Mahabadi A.A., Berg M.H., Lehmann N., et al. Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study. JAm Coll Cardiol 2013, 61(13):1388-1395.
59. Forouzandeh F., Chang S.M., Muhyieddeen K., et al. Does quantifying epicardial and intrathoracic fat with noncontrast computed tomography improve risk stratification beyond calcium scoring alone?. Circ Cardiovasc Imaging 2013, 6(1):58-66.
60. Raggi P., Boulay A., Chasan-Taber S., et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. JAm Coll Cardiol 2002, 39(4):695-701.
61. Turan M.N., Gungor O., Asci G., et al. Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients. Atherosclerosis 2013, 226(1):129-133.
62. D'Marco L.G., Bellasi A., Kim S., Chen Z., Block G.A., Raggi P. Epicardial adipose tissue predicts mortality in incident hemodialysis patients: a substudy of the Renagel in new dialysis trial. Nephrol Dial Transplant 2013, 28:2586-2595.
63. Guaraldi G., Scaglioni R., Zona S., et al. Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients. AIDS 2011, 25(9):1199-1205.
64. Lipson A., Alexopoulos N., Hartlage G.R., et al. Epicardial adipose tissue is increased in patients with systemic lupus erythematosus. Atherosclerosis 2012, 223(2):389-393.
65. Ormseth M.J., Lipson A., Alexopoulos N., et al. Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2013, 65(9):1410-1415.
66. Orlando G., Guaraldi G., Zona S., et al. Ectopic fat is linked to prior cardiovascular events in men with HIV. JAcquir Immune Defic Syndr 2012, 59(5):494-497.
67. Zona S., Raggi P., Bagni P., et al. Parallel increase of subclinical atherosclerosis and epicardial adipose tissue in patients with HIV. Am Heart J 2012, 163(6):1024-1030.
68. Manzi S., Meilahn E.N., Rairie J.E., et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997, 145(5):408-415.
69. Maradit-Kremers H., Crowson C.S., Nicola P.J., et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005, 52(2):402-411.
70. Kim W.J., Bae E.M., Kang Y.J., et al. Glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques. Immunology 2006, 119(3):421-429.
71. Avina-Zubieta J.A., Abrahamowicz M., De Vera M.A., et al. Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatol (Oxford) 2013, 52(1):68-75.
72. Lehman S.J., Massaro J.M., Schlett C.L., O'Donnell C.J., Hoffmann U., Fox C.S. Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis 2010, 210(2):656-661.
73. Britton K.A., Pedley A., Massaro J.M., et al. Prevalence, distribution, and risk factor correlates of high thoracic periaortic fat in the Framingham Heart Study. JAm Heart Assoc 2012, 1(6):e004200.
74. Fox C.S., Massaro J.M., Schlett C.L., et al. Periaortic fat deposition is associated with peripheral arterial disease: the Framingham heart study. Circ Cardiovasc Imaging 2010, 3(5):515-519.
75. Ohman M.K., Luo W., Wang H., et al. Perivascular visceral adipose tissue induces atherosclerosis in apolipoprotein E deficient mice. Atherosclerosis 2011, 219(1):33-39.
76. Kim M.K., Tanaka K., Kim M.J., et al. Comparison of epicardial, abdominal and regional fat compartments in response to weight loss. Nutr Metab Cardiovasc Dis 2009, 19(11):760-766.
77. Nakazato R., Rajani R., Cheng V.Y., et al. Weight change modulates epicardial fat burden: a 4-year serial study with non-contrast computed tomography. Atherosclerosis 2012, 220(1):139-144.
78. Fu C.P., Sheu W.H., Lee I.T., et al. Effects of weight loss on epicardial adipose tissue thickness and its relationship between serum soluble CD40 ligand levels in obese men. Clin Chim Acta 2013, 421:98-103.
79. Aghamohammadzadeh R., Greenstein A.S., Yadav R., et al. Effects of bariatric surgery on human small artery function: evidence for reduction in perivascular adipocyte inflammation, and the restoration of normal anticontractile activity despite persistent obesity. JAm Coll Cardiol 2013, 62(2):128-135.
80. Takase H., Dohi Y., Okado T., Hashimoto T., Goto Y., Kimura G. Effects of ezetimibe on visceral fat in the metabolic syndrome: a randomised controlled study. Eur J Clin Invest 2012, 42(12):1287-1294.
81. Alexopoulos N., Melek B.H., Arepalli C.D., et al. Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning). JAm Coll Cardiol 2013, 61(19):1956-1961.
82. Finelli C., Sommella L., Gioia S., La Sala N., Tarantino G. Should visceral fat be reduced to increase longevity?. Ageing Res Rev 2013, 12:996-1004.
83. Manco M., Morandi A., Marigliano M., Rigotti F., Manfredi R., Maffeis C. Epicardial fat, abdominal adiposity and insulin resistance in obese pre-pubertal and early pubertal children. Atherosclerosis 2013, 226(2):490-495.
84. Raggi P. Epicardial adipose tissue as a marker of coronary artery disease risk. JAm Coll Cardiol 2013, 61(13):1396-1397.
85. Mazurek T., Zhang L., Zalewski A., et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003, 108(20):2460-2466.
86. Hirata Y., Kurobe H., Akaike M., et al. Enhanced inflammation in epicardial fat in patients with coronary artery disease. Int Heart J 2011, 52(3):139-142.
87. Hirata Y., Tabata M., Kurobe H., et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. JAm Coll Cardiol 2011, 58(3):248-255.
88. Shibasaki I., Nishikimi T., Mochizuki Y., et al. Greater expression of inflammatory cytokines, adrenomedullin, and natriuretic peptide receptor-C in epicardial adipose tissue in coronary artery disease. Regul Pept 2010, 165(2-3):210-217.
89. Konishi M., Sugiyama S., Sato Y., et al. Pericardial fat inflammation correlates with coronary artery disease. Atherosclerosis 2010, 213(2):649-655.
90. Langheim S., Dreas L., Veschini L., et al. Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. Am J Physiol Heart Circ Physiol 2010, 298(3):H746-H753.
91. Schafer K., Konstantinides S.V. Update on the cardiovascular risk in obesity: endocrine and paracrine role of the adipose tissue. Hell J Cardiol 2011, 52(4):327-336.
92. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7(8):941-946.
93. Adeghate E. Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions. Curr Med Chem 2008, 15(18):1851-1862.
94. Mattu H.S., Randeva H.S. Role of adipokines in cardiovascular disease. JEndocrinol 2013, 216(1):T17-T36.
95. Cheng K.H., Chu C.S., Lee K.T., et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 2008, 32(2):268-274.
96. Bambace C., Telesca M., Zoico E., et al. Adiponectin gene expression and adipocyte diameter: a comparison between epicardial and subcutaneous adipose tissue in men. Cardiovasc Pathol 2011, 20(5):e153-156.
97. Eiras S., Teijeira-Fernandez E., Salgado-Somoza A., et al. Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression. Cytokine 2010, 51(2):207-212.
98. Marchington J.M., Mattacks C.A., Pond C.M. Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B 1989, 94(2):225-232.
99. Pezeshkian M., Noori M., Najjarpour-Jabbari H., et al. Fatty acid composition of epicardial and subcutaneous human adipose tissue. Metab Syndr Relat Disord 2009, 7(2):125-131.
100. Malavazos A.E., Ermetici F., Cereda E., et al. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity. Nutr Metab Cardiovasc Dis 2008, 18(8):523-530.
101. Schiffrin E.L. The immune system: role in hypertension. Can J Cardiol 2013, 29(5):543-548.
102. Harrison D.G., Guzik T.J., Lob H.E., et al. Inflammation, immunity, and hypertension. Hypertension 2011, 57(2):132-140.